The Cystic Fibrosis Foundation today applauds the Food and Drug Administration's approval of Kalydeco™ (ivacaftor; previously known as VX-770), a major advance in the search for a cure for cystic fibrosis.
Dec. 21, 2012
|
2 min read
Jan. 31, 2012
|
3 min read
Sept. 29, 2006
|
1 min read
An observation by surfers in Australia has led to a simple, inexpensive hypertonic saline therapy.
Jan. 18, 2006
|
3 min read
Jan. 18, 2006
|
3 min read